ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3230

Perceived Barriers in Care for Arthritis

Elizabeth M. Badley1, Lynn Moore2 and Monique A.M. Gignac3, 1Toronto Western Research Institute, Toronto, ON, Canada, 2The Arthritis Society, Toronto, ON, Canada, 3Instititue for Work and Health, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Advocacy, Education, patient and website

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: ARHP IV: Clinical Practice and Patient Care

Session Type: ARHP Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: To examine current arthritis treatments, barriers to treatment, and perceptions of health care decision making, especially preferences for patient-physician shared input.

Methods: A poll of people with arthritis was commissioned to gather data on patient perceptions with the purpose of improving information on the web site of The Arthritis Society of Canada. Respondents were asked for their disease diagnosis; impact of arthritis (e.g., pain, fatigue, disability with activities and social roles); challenges in getting care; and preferences for physician involvement in care decisions.  Most questions were on a 1 to 5 scale ranging from 1 = no impact/importance to 5 = extreme impact/importance. Scores are reported as means or percentages unless otherwise stated.

Results:

Of the 1514 respondents, 558 reported only osteoarthritis (OA) and 1043 reported inflammatory arthritis (IA) (rheumatoid arthritis 499, psoriatic arthritis 235, ankylosing spondylitis 227, lupus 156).  69% were female; 69% were aged <65 years; 65% were married and 46% had completed post-secondary education.  Mean disease duration was 12.9 years.  There were few  differences in findings by disease. Mean pain intensity was 6.0 (95% CI: 5.9-6.1) (1 to 10 scale). Mean number of joints (out of 13) was 4.3 (95% CI: 3.9-4.8), slightly less for OA (mean 3.8; 95% CI:3.6-4.0).  The impact on daily activities was moderate with mean scores in the range of 2.6 to 4.0.  The greatest impact was for intimate relations (4.0) and exercise (3.4). Respondents reported controlling pain, mobility and fatigue as being of high importance (mean score range 4.1-4.4).  52% reported taking medication orally; 15% by injection or infusion (mainly respondents with IA).  Overall, 75% of respondents reported at least one challenge in getting treatment. The top 3  challenges were lack of affordable treatment  (27.5%), long wait times for appointments (28.8%), and a perceived absence of beneficial treatments (e.g., ”don’t think anything can be done”) (21.2%). Costs for treatments like physiotherapy and medication were noted in particular. Younger respondents tended to report more challenges.  A sizable minority reported that nothing could be done for their arthritis (range 16.2 % to 26.3 % by disease). Respondents rated highly the importance of physician input when making decisions related to prescription medication (mean = 4.4) and surgery or physiotherapy (mean = 4.4). They expressed lower importance of seeking physician input on treatments like diet and exercise (mean = 3.7) and over-the counter-medications (mean = 3.8).

Conclusion: Despite pain, a moderate impact on valued roles and activities, and a high importance of controlling a range of symptoms, most respondents reported challenges with getting treatment, including costs not covered by the health care system.  Of concern is the perception of some that little was available in the way of efficacious care. There is a need for better patient information on what can be done to control arthritis and for interventions to minimize barriers in accessing appropriate treatments. Additional research on decision-making preferences would be beneficial in addressing a patient-centered approach to care.


Disclosure: E. M. Badley, None; L. Moore, None; M. A. M. Gignac, None.

To cite this abstract in AMA style:

Badley EM, Moore L, Gignac MAM. Perceived Barriers in Care for Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/perceived-barriers-in-care-for-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perceived-barriers-in-care-for-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology